Accès ouvert · CC BY

Identification of novel germline and somatic mutations associated with hepatocellular carcinoma by next-generation sequencing

Article scientifique 2026 Sciences de la santé Anglais

Résumé

Background Hepatocellular carcinoma (HCC) is the third leading cause of cancer-associated deaths worldwide with an estimated of 900,000 new cases annually. HCC typically arises in patients with chronic liver disease, including hepatitis, cirrhosis, and non-alcoholic fatty liver diseases. Identifying of the main driver genetic alterations in oncogenic genes is essential for understanding HCC pathogenesis and defining prognostic biomarkers in high-risk patients. This study aimed to identify both germline and somatic mutations associated with HCC in a Tunisian patient’s cohort. Methods Forty HCC patients with different etiologies were included in this study. Peripheral blood samples were collected from 24 patients with advanced-stage HCC. Paired tumor and adjacent non-tumoral liver tissue samples were obtained from 16 early-stage HCC patients undergoing hepatic resection, including 10 fresh-frozen samples and 6 FFPE samples. DNA was extracted using the MagCore® Plus II system. Targeted next-generation sequencing was performed using the Illumina AmpliSeq™ Cancer Hotspot Panel v2 . Results A total of 35 germline mutations were identified across 25 genes. Recurrently altered genes included FGFR3 (100%), PDGFRA (100%), RET (98%), APC (92%), TP53 (88%), and EGFR (75%). In addition, 14 somatic mutations were detected in 13 genes, with frequent alterations observed in APC (100%), ALK (94%), HNF1A (56%), CDKN2A (50%), and HRAS (50%). Conclusion This study offers the first comprehensive overview of novel germline and somatic mutations in Tunisian HCC patients, representing a North African cohort, and highlights key molecular drivers of hepatocarcinogenesis. These findings support the integration of genetic profiling into clinical practice to enhance early diagnosis and guide personalized therapies.

Citer ce document

Laaribi, A. B., Babay, W., Lekired, A., Bouchabou, B., Mehri, A., Bacha, D., Sassi, R., Slama, S. B., Bayar, R., Omrani, S., Boujelbène, N., Ennaifer, R., Arfa, N., Lahmar, A., & Ouzari, H.-I. (2026). Identification of novel germline and somatic mutations associated with hepatocellular carcinoma by next-generation sequencing. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2025.1699280

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 29/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 12

Téléchargements (hors robots) : 0

Méthode de comptage